click below
click below
Normal Size Small Size show me how
PHO 1
PAIN, HEMATOLOGY, AND ONCOLOGY 1
| Pharmacologic Category | Generic | Brand | Classification | Common Indications | Essential Knowledge |
|---|---|---|---|---|---|
| Opioid analgesic | fentanyl (transdermal, IV) | Transdermal: Duragesic, IV: Sublimaze | CS-II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) BBW: potential for errors when converting between dosage forms; use w/ CYP3A4 inhibitors can increase fentanyl concentrations; |
| Opioid analgesic | hydromorphone (PO, IV) | Dilaudid | CS-II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) US Boxed Warning: risk of medication errors with high-potency hydromorphone, use in opioid-tolerant patients only |
| Opioid analgesic | morphine (extended release) (PO) | MS Contin, Kadian | CS-II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) US Boxed Warning: coingestion with alcohol may result in potentially fatal overdose of morphine |
| Opioid analgesic | morphine (immediate release) (PO, IV, IM, PR) | IV: Duramorph, Infumorph | CS-II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) US Boxed Warning: use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations |
| Opioid analgesic | oxycodone (PO) | OxyContin, Roxicodone | CS-II | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) |
| Opioid analgesic | methadone (PO, IV) | Dolophine | CS-II | Opioid use disorder, severe chronic pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related), QTc prolongation BBW: QTc prolongation and arrhythmia concomitant use with CYP3A4, 2B6, 2C19, or 2D6 increase conc. |
| Analgesic (non-opioid), antipyretic | acetaminophen (PO, PR, IV) | PO/PR: Tylenol, IV: Ofirmev | PO, PR: OTC | Pain, fever | Key Side Effects: nausea, vomiting, increased hepatic transaminases |
| Central analgesic; partial opioid agonist | tramadol (PO) | Ultram, Ultram ER | CS-IV | Pain | Key Side Effects: dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related) |